Comparison of Nutraceuticals Use and Outcomes in COVID-19 Patients Vs Non-COVID-19 Population

Abstract

Background: Nutraceuticals, representing a synergy between nutrition and pharmaceuticals, are gaining traction due to increasing awareness of their health benefits. As dietary supplements become integrated into pharmacological treatments, their role in managing health conditions, including COVID-19, is of significant interest.

Objective: This study aims to explore the use of nutraceuticals among individuals who have recovered from COVID-19 compared to those who have never contracted the virus, focusing on the patterns of usage and associated side effects.

Methods: A cross-sectional online survey was conducted from April to June 2023, targeting a diverse population of COVID-19 survivors and non-infected individuals. The survey captured data on demographics, vaccination status, nutraceutical use, and any adverse effects experienced. A total of 250 participants were recruited to provide a broad perspective on the dietary supplementation habits among these groups.

Results: Of the total participants, 65.1% (n=163) were non-COVID-19 individuals, and 34.9% (n=87) had recovered from COVID-19. Nutraceuticals were more commonly used by non-COVID-19 individuals, with multivitamins and folates being the most frequently consumed supplements. Notably, 77% of non-COVID-19 individuals reported side effects, predominantly an unpleasant taste, compared to 23% of COVID-19 survivors experiencing similar issues.

Conclusion: The findings indicate a higher utilization of nutraceuticals among non-COVID-19 individuals, with multivitamins and folates being predominant. Side effects were more prevalent in non-COVID-19 participants. Future research should further investigate the specific benefits and risks of nutraceuticals to better understand their role in health management and recovery post-COVID-19.